Abiopharma

United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP® for Treatment of Acute Liver Failure

Loblaw Companies Limited Announces the Timing of the First Quarter 2026 Earnings Release and Annual Meeting of Shareholders

BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions

Capital City Bank Group, Inc. to Announce Quarterly Earnings Results on Monday, April 20, 2026

Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update

Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026

Henry Schein to Reduce Size of the Board of Directors following 2026 Annual Meeting of Stockholders

Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference

Trinity Industries, Inc. Announces Date for Earnings Release

BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union